info@ehidc.org

 202-624-3270

UHC Collaborates with Janssen to Accelerate COVID-19 Vaccine Research

The coronavirus continues to have a profound impact on the health of people around the world, in particular those who may be at higher risk for symptomatic infection, including older people, essential workers and diverse communities that have been disproportionately affected.

To help advance efforts to prevent the disease, UnitedHealth Group is collaborating with Johnson & Johnson and its Janssen Pharmaceutical Companies to share information about their Phase 3 COVID-19 vaccine candidate trial to members, customers and employees to help meet enrollment goals.

External News Article: 
Add reference to external site news article
News Category: 
Member News